Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-30 |
filingDate |
1988-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1989-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a111251bb6e873ee925a89dd865dd611 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca0c34add22ceb2dc608c06e6b635cdc |
publicationDate |
1989-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-4855321-A |
titleOfInvention |
Antihypercholesterolemic compounds |
abstract |
Novel 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors which are useful as antihypercholesterolemic agents and are represented by the following general structural formulae (I) and (II): ##STR1## and pharmaceutically acceptable salts of the compounds (II) in which Z is hydrogen are disclosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-628145-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5169976-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5939583-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5393780-A |
priorityDate |
1986-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |